Three Novel COVID-19 Pneumonia Cases Successfully Treated With Lopinavir/Ritonavir

Tatsuhiko Wada1, Kosuke Shimode1, Takayuki Hoshiyama1,2

  • 1Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine, Sagamihara, Japan.

Frontiers in Medicine
|June 24, 2020
PubMed

Insights

Lopinavir/Ritonavir (LPV/r) effectively treated non-severe COVID-19 pneumonia in three elderly patients. This antiviral treatment offers a potential option for managing mild Coronavirus Disease 2019 cases.

Area of Science:

  • Infectious Diseases
  • Virology
  • Pulmonology

Background:

  • The global spread of Coronavirus Disease 2019 (COVID-19), caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), necessitates effective treatment strategies.
  • Early outbreaks included community transmission following a cruise ship incident in Japan.

Observation:

  • Three patients admitted to Kitasato University Hospital presented with pneumonia.
  • COVID-19 diagnosis was confirmed via real-time reverse transcriptase-polymerase chain reaction (RT-PCR) testing for SARS-CoV-2 nucleic acid.
  • All patients were diagnosed with non-severe COVID-19 pneumonia.

Findings:

  • Successful treatment of non-severe COVID-19 pneumonia was achieved using Lopinavir/Ritonavir (LPV/r).
  • The treatment was effective even in elderly patients.

Implications:

  • Lopinavir/Ritonavir (LPV/r) presents a viable therapeutic option for non-severe COVID-19 pneumonia.
  • This finding is particularly relevant for managing mild cases in the elderly population.

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
655
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
48.9K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.2K
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
627
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
688
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
420